Perrigo Co. PLCis shipping the first generic equivalent of Bayer AG's Zegerid OTC proton pump inhibitor six years after filing an abbreviated new drug application and after two separate patent infringement litigations were settled.
The omeprazole/20mg and sodium bicarbonate/1,100mg capsules indicated for the treatment of frequent heartburn from the private-label giant will bear labeling that has been through several updates since the first PPI...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?